HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of topical ketoconazole in cutaneous leishmaniasis.

Abstract
The efficacy of topical ketoconazole in cutaneous leishmaniasis (CL) caused by L. major was assessed in an open trial. Ten patients with twenty two lesions of CL, confirmed by smear/or biopsy, were recruited into the study. Of the twenty two lesions treated, three increased in size and lesion characteristics worsened, ten showed no change but in nine there was some improvement in lesion characteristics. No lesion healed completely. No side effects were reported in nine. Topically applied ketoconazole is safe but does not significantly alter the course of CL. The differences in the results of systematically administered and topically applied ketoconazole may be due to differences in the pharmacokinetics of the drug when it is administered by different routes.
AuthorsA Abahusein, E B Larbi, A al-Khawajah, Y al-Gindan, S Jain
JournalEast African medical journal (East Afr Med J) Vol. 69 Issue 1 Pg. 14-7 (Jan 1992) ISSN: 0012-835X [Print] Kenya
PMID1628541 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ketoconazole
Topics
  • Administration, Oral
  • Administration, Topical
  • Adult
  • Child, Preschool
  • Female
  • Humans
  • Ketoconazole (administration & dosage)
  • Leishmaniasis, Cutaneous (drug therapy)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: